Toceranib Phosphate
1,093 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
1,093
Total Reports
138
Deaths Reported
1260.0%
Death Rate
Active Ingredients
Toceranib Phosphate
Administration Routes
OralUnknownTopicalOtherSubconjunctivalRectalOphthalmic
Species Affected
Dog 891
Cat 97
Unknown 79
Human 25
Other Rodents 1
Most Affected Breeds
Retriever - Labrador 105
Unknown 104
Dog (unknown) 78
Retriever - Golden 48
Domestic Shorthair 47
Boxer (German Boxer) 41
Mixed (Dog) 39
Terrier - Bull - American Pit 31
Crossbred Canine/dog 30
Pug 28
Most Reported Reactions
Diarrhoea 189
Vomiting 170
Anorexia 131
Lethargy (see also Central nervous system depression in 'Neurological') 86
Lack of efficacy - NOS 85
Anaemia NOS 83
Lameness 82
Weight loss 80
Death by euthanasia 78
Neutropenia 76
Leucopenia NOS 72
Elevated serum alkaline phosphatase (SAP) 71
Outcome Breakdown
Ongoing
506 (55.7%)
Outcome Unknown
161 (17.7%)
Recovered/Normal
102 (11.2%)
Died
80 (8.8%)
Euthanized
59 (6.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.